US Stock MarketDetailed Quotes

Regeneron Pharmaceuticals (REGN)

Watchlist

718.490
-1.390-0.19%

Trading May 14 10:08 ET

75.33BMarket Cap17.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals (REGN) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

3.23%1.08B

12.63%4.98B

-7.29%1.17B

25.36%1.62B

223.28%1.14B

-30.90%1.05B

-3.78%4.42B

15.89%1.26B

15.88%1.29B

-65.38%354M

Net income from continuing operations

-10.08%727.2M

2.09%4.5B

-7.97%844.6M

8.91%1.46B

-2.84%1.39B

12.01%808.7M

11.61%4.41B

-20.86%917.7M

33.02%1.34B

47.90%1.43B

Operating gains losses

82.13%-25M

-699.75%-946.1M

-89.90%21.5M

-328.88%-577.7M

36.32%-250M

-171.34%-139.9M

-144.41%-118.3M

466.44%212.9M

-206.06%-134.7M

-1,370.55%-392.6M

Depreciation and amortization

-2.92%123.2M

12.59%543.7M

14.72%145M

12.33%136.7M

11.93%135.1M

11.22%126.9M

14.70%482.9M

11.86%126.4M

15.46%121.7M

17.07%120.7M

Deferred tax

30.98%-96M

-3.71%-785.4M

17.02%-232.5M

-65.24%-278.6M

-14.48%-135.2M

26.94%-139.1M

9.61%-757.3M

2.13%-280.2M

-34.13%-168.6M

43.57%-118.1M

Other non cash items

1,637.50%55.6M

275.35%135.5M

101.32%136.9M

156.21%16.3M

-596.67%-20.9M

3,100.00%3.2M

36,200.00%36.1M

488.57%68M

-145.76%-29M

-134.88%-3M

Change In working capital

-71.84%36.5M

186.14%532.6M

106.83%5.9M

1,078.09%625M

74.91%-227.9M

-70.58%129.6M

-557.07%-618.3M

-40.72%-86.4M

66.77%-63.9M

-1,017.47%-908.5M

-Change in receivables

-99.82%1.2M

189.91%498.1M

56.54%-51.2M

79.35%-80.3M

94.29%-28.2M

47.22%657.8M

-63.52%-554M

-42.44%-117.8M

16.09%-388.9M

-18,200.00%-494.1M

-Change in inventory

117.47%26.6M

55.58%-275.3M

101.78%2.1M

49.76%-82.6M

76.62%-42.5M

2.25%-152.3M

-128.08%-619.7M

-148.84%-117.7M

-112.95%-164.4M

-81.08%-181.8M

-Change in prepaid assets

-10.64%-198.6M

7.90%-375.3M

249.73%82.8M

-119.01%-47.9M

56.17%-230.7M

-130.42%-179.5M

-239.30%-407.5M

-133.66%-55.3M

191.47%252M

-15,379.41%-526.3M

-Change in payables and accrued expense

150.30%107.7M

0.23%736.8M

-110.95%-24.7M

290.53%759.2M

5.77%216.4M

-293.76%-214.1M

22.80%735.1M

262.65%225.6M

-66.40%194.4M

415.37%204.6M

-Change in other working capital

462.71%99.6M

-122.70%-51.7M

85.38%-3.1M

78.14%76.6M

-260.38%-142.9M

-84.86%17.7M

501.06%227.8M

-149.30%-21.2M

-5.08%43M

714.48%89.1M

Cash from discontinued investing activities

Operating cash flow

3.23%1.08B

12.63%4.98B

-7.29%1.17B

25.36%1.62B

223.28%1.14B

-30.90%1.05B

-3.78%4.42B

15.89%1.26B

15.88%1.29B

-65.38%354M

Investing cash flow

Cash flow from continuing investing activities

-166.24%-428.9M

74.51%-629.1M

-37.16%220.3M

29.86%-402.9M

-96.34%-1.09B

138.38%647.5M

22.51%-2.47B

629.61%350.6M

-15.74%-574.4M

76.66%-557.2M

Capital expenditure reported

-0.57%-230.6M

-18.85%-898.4M

-24.60%-248.7M

16.74%-201.4M

-21.33%-219M

-71.25%-229.3M

-5.19%-755.9M

20.60%-199.6M

-37.44%-241.9M

-59.73%-180.5M

Net PPE purchase and sale

----

--0

----

--20.1M

--0

----

Net intangibles purchase and sale

-15.88%-48.9M

-150.84%-315.3M

37.69%-42M

---43.3M

-517.76%-187.8M

-51.25%-42.2M

39.51%-125.7M

-8.53%-67.4M

--0

-45.45%-30.4M

Net business purchase and sale

----

80.00%-3.3M

97.39%-300K

---3M

----

69.95%-16.5M

-202.63%-11.5M

--0

----

Net investment purchase and sale

-116.26%-149.4M

136.97%587.9M

-18.73%511.3M

53.32%-155.2M

-90.15%-687.2M

160.25%919M

27.85%-1.59B

150.54%629.1M

-35.55%-332.5M

83.96%-361.4M

Cash from discontinued investing activities

Investing cash flow

-166.24%-428.9M

74.51%-629.1M

-37.16%220.3M

29.86%-402.9M

-96.34%-1.09B

138.38%647.5M

22.51%-2.47B

629.61%350.6M

-15.74%-574.4M

76.66%-557.2M

Financing cash flow

Cash flow from continuing financing activities

26.35%-802.2M

-68.84%-3.72B

31.30%-780.1M

-13.23%-717.9M

-135.98%-1.13B

-2,412.53%-1.09B

-22.93%-2.2B

-154.54%-1.14B

-55.66%-634M

22.16%-478.1M

Net common stock issuance

28.49%-704.4M

-53.88%-3.33B

39.46%-687.4M

-4.35%-626.7M

-116.61%-1.04B

-2,191.51%-985.1M

-21.06%-2.17B

-154.54%-1.14B

-47.46%-600.6M

22.16%-478.1M

Cash dividends paid

-4.26%-97.8M

---370.3M

---92.7M

---91.2M

---92.6M

---93.8M

--0

Net other financing activities

----

69.16%-10.3M

--0

---10.3M

---33.4M

--0

----

Cash from discontinued financing activities

Financing cash flow

26.35%-802.2M

-68.84%-3.72B

31.30%-780.1M

-13.23%-717.9M

-135.98%-1.13B

-2,412.53%-1.09B

-22.93%-2.2B

-154.54%-1.14B

-55.66%-634M

22.16%-478.1M

Net cash flow

Beginning cash position

25.50%3.12B

-9.09%2.49B

24.92%2.51B

4.53%2.02B

18.51%3.09B

-9.09%2.49B

-12.23%2.74B

-6.87%2.01B

-1.10%1.93B

-33.57%2.61B

Current changes in cash

-125.22%-152.2M

355.70%634.4M

27.83%610.9M

501.33%497.9M

-58.20%-1.08B

573.25%603.4M

34.92%-248.1M

-17.23%477.9M

-60.70%82.8M

65.57%-681.3M

Effect of exchange rate changes

-250.00%-900K

142.86%300K

57.14%-300K

-150.00%-400K

233.33%400K

220.00%600K

-75.00%-700K

-450.00%-700K

500.00%800K

25.00%-300K

End cash Position

-3.96%2.97B

25.50%3.12B

24.92%2.51B

4.53%2.02B

18.51%3.09B

-9.09%2.49B

-6.87%2.01B

-1.10%1.93B

Free cash flow

3.34%799.4M

6.39%3.77B

-11.63%880M

30.94%1.37B

415.44%737.6M

-42.73%773.6M

-3.51%3.54B

28.29%995.8M

14.75%1.05B

-83.89%143.1M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	3.23%1.08B	12.63%4.98B	-7.29%1.17B	25.36%1.62B	223.28%1.14B	-30.90%1.05B	-3.78%4.42B	15.89%1.26B	15.88%1.29B	-65.38%354M
Net income from continuing operations	-10.08%727.2M	2.09%4.5B	-7.97%844.6M	8.91%1.46B	-2.84%1.39B	12.01%808.7M	11.61%4.41B	-20.86%917.7M	33.02%1.34B	47.90%1.43B
Operating gains losses	82.13%-25M	-699.75%-946.1M	-89.90%21.5M	-328.88%-577.7M	36.32%-250M	-171.34%-139.9M	-144.41%-118.3M	466.44%212.9M	-206.06%-134.7M	-1,370.55%-392.6M
Depreciation and amortization	-2.92%123.2M	12.59%543.7M	14.72%145M	12.33%136.7M	11.93%135.1M	11.22%126.9M	14.70%482.9M	11.86%126.4M	15.46%121.7M	17.07%120.7M
Deferred tax	30.98%-96M	-3.71%-785.4M	17.02%-232.5M	-65.24%-278.6M	-14.48%-135.2M	26.94%-139.1M	9.61%-757.3M	2.13%-280.2M	-34.13%-168.6M	43.57%-118.1M
Other non cash items	1,637.50%55.6M	275.35%135.5M	101.32%136.9M	156.21%16.3M	-596.67%-20.9M	3,100.00%3.2M	36,200.00%36.1M	488.57%68M	-145.76%-29M	-134.88%-3M
Change In working capital	-71.84%36.5M	186.14%532.6M	106.83%5.9M	1,078.09%625M	74.91%-227.9M	-70.58%129.6M	-557.07%-618.3M	-40.72%-86.4M	66.77%-63.9M	-1,017.47%-908.5M
-Change in receivables	-99.82%1.2M	189.91%498.1M	56.54%-51.2M	79.35%-80.3M	94.29%-28.2M	47.22%657.8M	-63.52%-554M	-42.44%-117.8M	16.09%-388.9M	-18,200.00%-494.1M
-Change in inventory	117.47%26.6M	55.58%-275.3M	101.78%2.1M	49.76%-82.6M	76.62%-42.5M	2.25%-152.3M	-128.08%-619.7M	-148.84%-117.7M	-112.95%-164.4M	-81.08%-181.8M
-Change in prepaid assets	-10.64%-198.6M	7.90%-375.3M	249.73%82.8M	-119.01%-47.9M	56.17%-230.7M	-130.42%-179.5M	-239.30%-407.5M	-133.66%-55.3M	191.47%252M	-15,379.41%-526.3M
-Change in payables and accrued expense	150.30%107.7M	0.23%736.8M	-110.95%-24.7M	290.53%759.2M	5.77%216.4M	-293.76%-214.1M	22.80%735.1M	262.65%225.6M	-66.40%194.4M	415.37%204.6M
-Change in other working capital	462.71%99.6M	-122.70%-51.7M	85.38%-3.1M	78.14%76.6M	-260.38%-142.9M	-84.86%17.7M	501.06%227.8M	-149.30%-21.2M	-5.08%43M	714.48%89.1M
Cash from discontinued investing activities
Operating cash flow	3.23%1.08B	12.63%4.98B	-7.29%1.17B	25.36%1.62B	223.28%1.14B	-30.90%1.05B	-3.78%4.42B	15.89%1.26B	15.88%1.29B	-65.38%354M
Investing cash flow
Cash flow from continuing investing activities	-166.24%-428.9M	74.51%-629.1M	-37.16%220.3M	29.86%-402.9M	-96.34%-1.09B	138.38%647.5M	22.51%-2.47B	629.61%350.6M	-15.74%-574.4M	76.66%-557.2M
Capital expenditure reported	-0.57%-230.6M	-18.85%-898.4M	-24.60%-248.7M	16.74%-201.4M	-21.33%-219M	-71.25%-229.3M	-5.19%-755.9M	20.60%-199.6M	-37.44%-241.9M	-59.73%-180.5M
Net PPE purchase and sale	----	--0	--0	--0	----	----	--20.1M	--0	--0	----
Net intangibles purchase and sale	-15.88%-48.9M	-150.84%-315.3M	37.69%-42M	---43.3M	-517.76%-187.8M	-51.25%-42.2M	39.51%-125.7M	-8.53%-67.4M	--0	-45.45%-30.4M
Net business purchase and sale	----	80.00%-3.3M	97.39%-300K	---3M	----	----	69.95%-16.5M	-202.63%-11.5M	--0	----
Net investment purchase and sale	-116.26%-149.4M	136.97%587.9M	-18.73%511.3M	53.32%-155.2M	-90.15%-687.2M	160.25%919M	27.85%-1.59B	150.54%629.1M	-35.55%-332.5M	83.96%-361.4M
Cash from discontinued investing activities
Investing cash flow	-166.24%-428.9M	74.51%-629.1M	-37.16%220.3M	29.86%-402.9M	-96.34%-1.09B	138.38%647.5M	22.51%-2.47B	629.61%350.6M	-15.74%-574.4M	76.66%-557.2M
Financing cash flow
Cash flow from continuing financing activities	26.35%-802.2M	-68.84%-3.72B	31.30%-780.1M	-13.23%-717.9M	-135.98%-1.13B	-2,412.53%-1.09B	-22.93%-2.2B	-154.54%-1.14B	-55.66%-634M	22.16%-478.1M
Net common stock issuance	28.49%-704.4M	-53.88%-3.33B	39.46%-687.4M	-4.35%-626.7M	-116.61%-1.04B	-2,191.51%-985.1M	-21.06%-2.17B	-154.54%-1.14B	-47.46%-600.6M	22.16%-478.1M
Cash dividends paid	-4.26%-97.8M	---370.3M	---92.7M	---91.2M	---92.6M	---93.8M	--0	--0	--0	--0
Net other financing activities	----	69.16%-10.3M	--0	--0	--0	---10.3M	---33.4M	--0	----	----
Cash from discontinued financing activities
Financing cash flow	26.35%-802.2M	-68.84%-3.72B	31.30%-780.1M	-13.23%-717.9M	-135.98%-1.13B	-2,412.53%-1.09B	-22.93%-2.2B	-154.54%-1.14B	-55.66%-634M	22.16%-478.1M
Net cash flow
Beginning cash position	25.50%3.12B	-9.09%2.49B	24.92%2.51B	4.53%2.02B	18.51%3.09B	-9.09%2.49B	-12.23%2.74B	-6.87%2.01B	-1.10%1.93B	-33.57%2.61B
Current changes in cash	-125.22%-152.2M	355.70%634.4M	27.83%610.9M	501.33%497.9M	-58.20%-1.08B	573.25%603.4M	34.92%-248.1M	-17.23%477.9M	-60.70%82.8M	65.57%-681.3M
Effect of exchange rate changes	-250.00%-900K	142.86%300K	57.14%-300K	-150.00%-400K	233.33%400K	220.00%600K	-75.00%-700K	-450.00%-700K	500.00%800K	25.00%-300K
End cash Position	-3.96%2.97B	25.50%3.12B	25.50%3.12B	24.92%2.51B	4.53%2.02B	18.51%3.09B	-9.09%2.49B	-9.09%2.49B	-6.87%2.01B	-1.10%1.93B
Free cash flow	3.34%799.4M	6.39%3.77B	-11.63%880M	30.94%1.37B	415.44%737.6M	-42.73%773.6M	-3.51%3.54B	28.29%995.8M	14.75%1.05B	-83.89%143.1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm